Today: 22 May 2026
Applied Digital stock slides, then swings hard as new Buy call pegs $42 target — what’s next for APLD
22 January 2026
1 min read

Applied Digital stock slides, then swings hard as new Buy call pegs $42 target — what’s next for APLD

New York, January 21, 2026, 19:54 (EST) — After-hours

  • Applied Digital ended the day 1.1% lower at $35.06, following a volatile session.
  • Texas Capital kicked off coverage, assigning a Buy rating and setting a $42 price target
  • Investors await new lease and financing news related to its AI data-center expansion

Applied Digital (APLD.O) shares dipped 1.1%, finishing Wednesday at $35.06. Earlier, the stock swung between $38.00 and $32.33. Volume hit roughly 42.1 million shares.

The stock now acts as a stand-in for a tight race: who can grab power, scale quickly, and lock in lengthy contracts for AI workloads. Even minor news can trigger shifts, and the volatility runs both directions.

This matters because the market is valuing future megawatts — the power capacity that determines how many servers a data center can support — well before the facilities are operational. Investors keep coming back to one key issue: execution and the funding behind it.

Texas Capital’s Derrick Whitfield kicked off coverage with a Buy rating and set a $42 price target, highlighting the company’s “waterless cooling” technology and its land-and-power portfolio, which could reach up to 4.3 gigawatts. TipRanks

Applied Digital is positioning itself as an “AI Factory” developer in North Dakota, focusing on long-term leases for high-performance computing (HPC), the intensive processing needed for AI model training and operation. In its latest quarterly update earlier this month, the company reported 600 megawatts leased across two campuses, including a 400-MW buildout for CoreWeave and a nearly 15-year, 200-MW lease with another investment-grade hyperscaler. It also highlighted major financing moves, like a $2.35 billion private notes offering and preferred equity draws with Macquarie, to support ongoing construction. Applied Digital Corporation

But the trade isn’t straightforward. The stock trades as if it’s a developer with locked-in tenants and set delivery timelines. The risks are well-known: construction hold-ups, delayed customer approvals, or rising financing costs that eat into returns before cash flow kicks in.

Timing also remains a hurdle. The investor relations calendar lists no events on the horizon, pushing traders to sift through filings, track project milestones, and watch for new lease disclosures to gauge momentum.

The next major event to watch is Applied Digital’s upcoming earnings report. Zacks and other market trackers have April 13, 2026, penciled in for the release, even though the company hasn’t officially confirmed a date on its own calendar.

Stock Market Today

  • NYSE's Martin Questions Nasdaq Rules Attracting SpaceX IPO
    May 22, 2026, 9:22 AM EDT. Lynn Martin, President of the New York Stock Exchange (NYSE), criticized some of the Nasdaq's listing rules used to attract SpaceX's public offering as "questionable." Speaking on Bloomberg Surveillance, Martin emphasized that market integrity should not be compromised for competitive gains between stock exchanges. She noted 2023 has been a strong year for initial public offerings (IPOs) across sectors and affirmed the NYSE's commitment to bringing more companies public. Martin's remarks highlight ongoing debates over regulatory standards and competitive practices in the IPO market.

Latest articles

Akari Therapeutics Stock Is Soaring Again — The KRAS Cancer Data Behind the Move

Akari Therapeutics Stock Is Soaring Again — The KRAS Cancer Data Behind the Move

22 May 2026
New York, May 22, 2026, 09:08 EDT Akari Therapeutics shares were indicated sharply higher before the Nasdaq open on Friday, after the oncology biotech said its lead cancer drug candidate showed positive preclinical activity in KRAS-mutated pancreatic cancer models and priced a $5.5 million private placement. The stock closed Thursday at $5.14, up 49.85%, and was quoted at $10.15 in premarket trading at 8:39 a.m. EDT, according to StockAnalysis. The move matters because Akari is still a preclinical company, not a revenue-producing drugmaker. Its latest data give investors a fresh reason to look at AKTX-101, while the financing gives the
BMO Lands Buy Rating Ahead of Earnings But Targets Raise Questions

BMO Lands Buy Rating Ahead of Earnings But Targets Raise Questions

22 May 2026
Canaccord Genuity reaffirmed a Buy rating on Bank of Montreal ahead of its May 27 earnings report. BMO shares closed May 21 at C$220.06, near a 52-week high and up 23.5% year-to-date. The bank recently agreed to sell C$14.5 billion in loan and lease assets to Stonepeak, expecting a CET1 ratio boost but a C$900 million after-tax charge. Analyst consensus remains mixed, with most holding or selling.
Atmos Energy’s run in Texas faces new Wall Street target cut

Atmos Energy’s run in Texas faces new Wall Street target cut

22 May 2026
Morgan Stanley lowered its Atmos Energy price target to $183 from $195, maintaining an Equalweight rating. The move follows Atmos’ recent increase in its 2026 earnings outlook and annual dividend. Atmos shares closed at $177.46 on Thursday. Texas remains central to Atmos’ growth and regulatory strategy, with 65% of its rate base in the state.
Applied Materials stock rebounds after tariff scare fades; what to watch next for AMAT
Previous Story

Applied Materials stock rebounds after tariff scare fades; what to watch next for AMAT

Credo (CRDO) stock slides 9% as insider sale filing hits tape and Rosenblatt starts at Neutral
Next Story

Credo (CRDO) stock slides 9% as insider sale filing hits tape and Rosenblatt starts at Neutral

Go toTop